期刊文献+

22例胃癌合并下肢深静脉血栓形成患者诊治特点分析 被引量:5

Diagnosis and treatment of 22 gastric cancer patients with lower limb deep venous thrombosis
下载PDF
导出
摘要 目的探讨胃癌合并下肢深静脉血栓形成(deep venous thrombosis,DVT)的临床特点及治疗情况。方法回顾性分析2008年8月-2014年11月我院收治的22例胃癌合并下肢DVT患者的临床资料,分析其临床特点及治疗情况。结果 22例中,男性18例,女性4例,年龄36~84(62.2±15.0)岁。胃腺癌22例(100%),Ⅳ期15例(68.2%),中低分化18例(81.8%)。19例(86.4%)DVT发生于胃癌确诊后,其中1~3个月累计发生12例。腹部手术治疗10例,其中5例于术后1个月内发生血栓。经抗凝治疗12例(54.5%),其中行下腔静脉滤器置入术3例,好转出院12例(54.5%)。结论胃癌确诊后及术后1~3个月是下肢DVT高发期,大部分确诊时为晚期且分化程度低,及时诊断、积极治疗可改善预后。 Objective To explore the clinical characteristics and treatment of gastric cancer with lower limb deep venous thrombosis(DVT).Methods Clinical data about 22 gastric cancer patients with lower limb DVT from August 2008 to November 2014 in our hospital were retrospectively analyzed.The clinical characteristics and treatment were recorded.Results Of all 22 patients,there were 18 males and 4 females with average age of(62.2±15.0) years(ranging from 36 to 84 years).Adenocacinoma was identified in 22(100%) patients,15(68.2%) patients were in stageⅣ and tumors in 18(81.8%) patients were moderately and/or low differentiated.DVT was diagnosed after the gastric cancer diagnosis in 19(86.4%) patients.After a definite diagnosis of cancer,12 patients experienced a thrombosis event within 3 months.Ten patients underwent abdominal surgery and 5 cases experienced a thrombosis event within the first month after surgery.Twelve(54.5%) patients received anticoagulant therapy and inferior vena cava filter placement was performed in 3 patients.Twelve(54.5%) patients improved when they were discharged.Conclusion The risk of DVT is the highest in the first 3 months after gastric cancer diagnosis or surgery.Most patients are diagnosed in late stage and have tumor with poor differentiation.Prompt diagnosis and aggressive treatment can improve the prognosis.
出处 《解放军医学院学报》 CAS 2016年第7期728-730,共3页 Academic Journal of Chinese PLA Medical School
关键词 胃癌 深静脉血栓形成 治疗 gastric cancer deep venous thrombosis therapy
  • 相关文献

参考文献18

  • 1Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 vl.1, Cancer Incidence and Mortality Worldwide : IARC CancerBase No. 11 [ EB/OL ] . http ://globocan.iarc.fr.
  • 2Khorana AA, Francis CW, Culakova E, et ah ThromI~oembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy [ J ] . J Thrnmb Haemost, 2007, 5 ( 3 ) : 632-634.
  • 3Elyamany G, Alzahrani AM, Bukhary E. Cancer-associated thrombosis : an overview [ J ] . Clin Med Insights Oncol, 2014, 8 : 129-137.
  • 4Brose KM, Lee AY. Cancer-associated Ihrombosis : prevention and treatment [ J ] . Curr Oncnl, 2008, 15 ( Suppl 1 ) : S58-S67.
  • 5Khorana AA, Dalai M, Lin J, et al. Incidence and predictors of venous thromboembolism ( VTE ) among ambulatory high-risk cancer patients undergoing chemotherapy in the Uniled States [ J ] . Cancer, 2013, 119 ( 3 ) : 648-655.
  • 6Lee AY. Thrmnbosis in cancer : an updale on prevenlion, Irealmenl, and survival benefits of anticoagulants [ J ] . Hematology Am Soc Hematol Educ Program, 2010 : 144-149.
  • 7Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients : the Sirius stmty [ J ] . Arch Intern Med, 2000, 160 ( 22 ) : 3415-3420.
  • 8Amer MH. Cancer-associated thrombosis : clinical presenladon and survival [J]. Cancer Manag Res, 2013, 5 : 165-178.
  • 9Tukaye DN, Brink H, Baliga R. Venous thrombooembolism in cancer patients : risk assessment, prevention and management [ J ] . l:tlture Cardiol, 2016, 12 ( 2 ) : 221-235.
  • 10Blom JW, Doggen CJ, Osanto S, et al. Malignancies, prothromboti, mutations, and the risk of venous thrombosis [ J j . JAMA, 2005, 293 ( 6 ) : 715-722.

二级参考文献31

  • 1刘玉珍,张震宇,郭淑丽,何文,张晓蓉,王淑珍,刘崇东,李金凤,李琳.妇科盆腔手术后下肢深静脉血栓形成的临床研究[J].中华妇产科杂志,2006,41(2):107-110. 被引量:191
  • 2陆慰萱.第13届血栓栓塞症国际研讨会纪要[J].中华内科杂志,2006,45(12):1035-1036. 被引量:8
  • 3林玉芝.恶性肿瘤患者术后并发下肢深静脉血栓的预防和护理体会[J].临床和实验医学杂志,2007,6(7):194-195. 被引量:3
  • 4Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology Guideline : recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol, 2007, 25:5490-5505.
  • 5Caine GJ, Stonelake PS, Lip GY, et al. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia, 2002, 4:465-473.
  • 6Tesselaar ME, Osanto S. Risk of venous thromboembolism in lung cancer. Curr Opin Pulm Med, 2007, 13:362-367.
  • 7Blom JW, Doggen CJ, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA, 2005, 293 : 715-722.
  • 8Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition ). Chest, 2008, 133 (6 suppl) :381S-453S.
  • 9Kuter DJ. Thrombotic complications of central venous catheters in cancer patients. The Oncologist, 2004, 9:207-216.
  • 10Monreala M, Trujillo-Santos J. Screening for occult cancer in patients with acute venous thromboembolism. Curr Opin Pulm Med, 2007, 13:368-371.

共引文献313

同被引文献34

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部